Comparison between usual and low doses of insulin in the assessment of insulin sensitivity with a short insulin tolerance test in obese women. 1999

M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
Unidad de Investigación Médica en Epidemiología Clínica, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico. uiec@jal1.telmex.net.mx

BACKGROUND The objective of this study is to compare, in obese women, the assessment of insulin sensitivity and the presence of hypoglycemia between the usual and low doses of insulin used in the short insulin tolerance test (ITT). METHODS The patients were 12 obese women on whom a randomized, double-masked, auto-controlled clinical trial was carried out. An ITT was performed on each volunteer in duplicate with insulin at 0.1 (usual dose) or 0.05 U/kg (low dose). RESULTS The constant for the rate serum glucose disappearance calculated for the ITT was not significantly different between both tests (4.3 +/- 0.5 vs. 4.4 +/- 1.0%/min, usual dose and low dose of insulin, respectively; p = 0.49). There was a significant correlation between both tests (r = 0.59, r2 = 0.34, p < 0.05). Differences between both tests had estimated limits of agreement of -0.97 to 0.65%/min. Between tests, the coefficient of variation was 16%. No subject developed hypoglycemia with any of the ITT measurements employing usual or low doses of insulin. CONCLUSIONS We recommend a low dose of insulin in the assessment of insulin sensitivity with ITT in obese people. In our study usual and low doses of insulin used in the ITT were safe and had similar results between both doses for assessing insulin sensitivity.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
June 1992, Diabetic medicine : a journal of the British Diabetic Association,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
October 2008, Diabetes research and clinical practice,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
May 1994, Clinical endocrinology,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
August 1996, Revista medica de Chile,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
July 2014, Nutricion hospitalaria,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
January 1994, Journal of the Society for Gynecologic Investigation,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
September 1983, Acta endocrinologica,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
January 1998, Clinical endocrinology,
M González-Ortiz, and E Martínez-Abundis, and S Pascoe-González
February 2011, Obesity (Silver Spring, Md.),
Copied contents to your clipboard!